Previous 10 | Next 10 |
Gainers: Medigus (MDGS) +36%, 180 Life Sciences (ATNF) +35%, Graybug Vision (GRAY) +23%, Trinity Biotech (TRIB) +18%, Accuray (ARAY) +14%.Losers: Bellerophon Therapeutics (BLPH) -18%, BioLineRx (BLRX) -13%, AIM ImmunoTech (AIM) -11%, iBio...
Trinity Biotech plc (TRIB) Q3 2020 Earnings Conference Call November 17, 2020 11:00 ET Company Participants Kevin Tansley - Chief Financial Officer Ronan O'Caoimh - Chairman & Chief Executive Officer John Gillard - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti &...
Trinity Biotech (TRIB): Q3 Non-GAAP EPS of $0.36; GAAP EPS of $0.32 beats by $0.22.Revenue of $32.01M (+30.2% Y/Y) beats by $4.01M.Press Release For further details see: Trinity Biotech EPS beats by $0.22, beats on revenue
DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. Quarter 3 Resul...
DUBLIN, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter 2020 on Tuesday, November 17, 2020. The Compan...
Kaixin Auto Holdings (KXIN) +57%.Midatech Pharma plc (MTP) +42% after announcing positive results from a Phase I study evaluating MTX110.Front Yard Residential (RESI) +34% after announcing going private deal valued at ~$2.4B.ARC Document Solutions (ARC) +26% on prelim...
Trinity Biotech plc (TRIB) Q2 2020 Earnings Conference Call Aug 25, 2020, 11:00 AM ET Company Participants Kevin Tansley - CFO Ronan O'Caoimh - Chairman & CEO Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Jim Sidoti - Sidoti ...
Trinity Biotech ( TRIB +2.4% ) reports Q2 revenue of $16.02M ( -28.8% Y/Y ), beating expectations by $3.02M. More news on: Trinity Biotech plc, Earnings news and commentary Read more ...
Trinity Biotech (NASDAQ: TRIB ) : Q2 GAAP EPSADR of $0.01. More news on: Trinity Biotech plc, Earnings news and commentary, Healthcare stocks news, , Read more ...
DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020. Quarter 2 Results ...
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...